We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Single Gene Leap Led to Flea Transmission of Plague

By Biotechdaily staff writers
Posted on 24 May 2002
A single gene change in a relatively benign recent ancestor of the bacterium that causes bubonic plague played a key role in the evolution of the deadly disease, researchers
have discovered. More...
Their findings were reported in the April 25, 2002, issue of Science.

By acquiring this gene, the bacterium gradually changed from a germ that caused a mild human stomach illness acquired from contaminated food or water to the flea-borne agent of the Black Death, which in the 14th century killed one-fourth of Europe's population.

Our research illustrates how a single genetic change can profoundly affect the evolution of disease. In this case, that genetic change set the stage for a completely new route of
disease transmission, notes B. Joseph Hinnebusch, Ph.D., lead author of the study and plague expert at Rocky Mountain Laboratories, a Montana (USA) outpost of the US National Institute of Allergy and Infectious Diseases (NIAID).

The gene allowed the bacteria to be transmitted through the bite of an insect--in this case, the flea--an adaptation that distinguishes Yersinia pestis, the plague germ, from closely related, more benign gut bacteria. In turn, as Y pestis adapted to rely on its new blood-feeding host for transmission, the emergence of more deadly bacterial strains would have been favored, the researchers conclude.

In the report, Dr. Hinnebusch and colleagues from Sweden, Michigan, and NIAID describe how they explored the source of this gene. The gene codes for an enzyme known as PLD. Previous work indicated that Y pestis picked up this gene from either an unrelated bacterium or a simple nucleated organism. The researchers infected fleas with variants of Y pestis that either contained or lacked the PLD gene and then observed the outcome. They discovered that the enzyme is required for survival of the plague bacterium in the midgut of the rat flea. Although the enzyme's activity protects Y pestis from being destroyed, the researchers do not yet know the molecular mechanism by which this protection occurs. To find that out is clearly the next step, Dr. Hinnebusch notes.
.

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.